Basepair Inc

Basepair Inc

Software Development

New York City, NY 5,019 followers

Combining easy NGS analysis & visualization for bench scientists w/ efficient scaling & deployment for bioinformaticians

About us

Basepair is a next generation bioinformatics company. Through a combination of intuitive interfaces and modern architecture we are reimagining what a commercial platform can deliver to R&D organizations. We're on a mission to make genomic data analysis & visualization more accessible to a broader range of scientists so that the promise of precision medicine can become a reality. One of the biggest challenges preventing this now arguably lies not with how the data gets generated and processed, but who is able to perform the analysis and understand what the resulting data means. Limiting this work to a select few, whether through choice or more often because of technology restrictions, especially for routine analyses, leads to reduced efficiency in R&D teams, longer times to market for assay manufacturers and increased turnaround times in clinical settings. Unlike other more traditional alternatives, our philosophy is not to ask bioinformaticians to change the way they work by having to build workflows on our platform. Instead, once they are built and ready for sharing or production settings, Basepair can significantly improve and accelerate both scaling & deployment to colleagues, collaborators and customers wherever they happen to be in the world. To do this in a way that is adapted to the dynamics of the market today, we believe a bioinformatics platform needs to: 1) Leverage the compute and storage resources in a third party cloud account without the requirement of installing inside an organization's vpc 2) Facilitate the bundling of analysis with the sale of a kit or assay through easy white labeling and tokens/coupons 3) Support ever increasing sample volumes and application areas through an extensible architecture that scales to millions of records, enables complete sample provenance and reduces cloud costs Introducing Basepair…bioinformatics reinvented.

Website
https://www.basepairtech.com
Industry
Software Development
Company size
11-50 employees
Headquarters
New York City, NY
Type
Privately Held
Founded
2017
Specialties
Genomics, B2B SaaS, White Labeling, Bioinformatics, Life Sciences, Analysis & Visualization, Next Generation Sequencing / NGS, AWS Partner, and Library Prep Kit Enablement

Locations

Employees at Basepair Inc

Updates

  • We are excited to welcome Gary Harton to Basepair Inc. as an Advisor to the Reproductive Genetic Health side of our business! With over 30 years of experience in the life sciences industry, Gary brings unparalleled expertise in reproductive health, genetics/genomics, and molecular biology. Gary has distinguished himself across a wide range of roles, both in and out of the lab. His impressive career includes leadership positions in leading genetics/genomics companies, executive roles in women’s health startups, and management of clinical IVF and genetics laboratories. His exceptional ability to develop and implement innovative genomic solutions will play a pivotal role in advancing Basepair’s mission to provide end-to-end genomic data analysis, and clinical sign state-of-the-art bioinformatics tools for researchers and clinicians. At Basepair, we are committed to delivering a modern ‘bench to bedside’ bioinformatics SaaS platform for genomic data analysis that eliminates data movement. With Gary’s deep industry insight and proven track record of driving market development, we are poised to further support groundbreaking discoveries and transform patient care. Please join us in warmly welcoming Gary Harton to the Basepair team as we continue to push the boundaries of innovation in the field of genomics. Together, we’re shaping the future of science and healthcare. #Basepair #Genomics #Bioinformatics #LifeSciences #Sequencing #ngs

    • No alternative text description for this image
  • ✨ As 2024 draws to a close, we want to extend our heartfelt thanks to our amazing partners and customers. Your collaboration and innovation have been the key to every breakthrough we’ve achieved this year. This year, we’ve connected at conferences and video calls, shared insights during demos, and delivered talks together that pushed the boundaries of what’s possible in bioinformatics. 🧬💻 Here’s to a 2025 with fewer errors, faster pipelines, and even more perfect pairings (pun intended). 🎉 #Bioinformatics #Basepair #HappyNewYear

    • No alternative text description for this image
  • View organization page for Basepair Inc, graphic

    5,019 followers

    🚀 ASHG 2024: Advancing Genomics Together Jason Fenwick’s recap of ASHG 2024 captures the excitement of this year’s innovations in human genetics. From Scale Bio announcing The 100 Million Cell Challenge Winning Projects to NVIDIA’s GPU-accelerated solutions powering large-scale single-cell and multi-omics studies, the future of genomics looks brighter than ever. As Jason Fenwick mentioned, "There were 4 words that popped up everywhere to describe what users want" for modern bioinformatics: 𝘴𝘪𝘮𝘱𝘭𝘦, 𝘧𝘭𝘦𝘹𝘪𝘣𝘭𝘦, 𝘱𝘰𝘸𝘦𝘳𝘧𝘶𝘭, 𝘢𝘯𝘥 𝘵𝘳𝘢𝘯𝘴𝘱𝘢𝘳𝘦𝘯𝘵." Basepair is proud to work in modernizing bioinformatics: 1. 𝗦𝗶𝗺𝗽𝗹𝗲: SaaS Point-and-click enterprise wrapper with +80 ready-to-go pipelines available for all data types plus CLI to scale and deploy your own custom workflows in Nextflow, WDL, CWL, and Snakemake. 2. 𝗙𝗹𝗲𝘅𝗶𝗯𝗹𝗲: Per sample licensing models. You only pay for what you use, not what you anticipate might be your usage in the next twelve months. 3. 𝗣𝗼𝘄𝗲𝗿𝗳𝘂𝗹: GUI for HealthOmics and Parabricks-GPU accelerated tools. 4. 𝗧𝗿𝗮𝗻𝘀𝗽𝗮𝗿𝗲𝗻𝘁: Provision inside your AWS account (for both storage AND compute) so you are in control of your IT governance, security, and usage commitments with your cloud provider. Read Jason’s article for more highlights: https://lnkd.in/gHJVyTXX #Genomics #ASHG2024 #Bioinformatics #Innovation

    An Omics Wonderland in Denver - ASHG 2024 Roundup

    An Omics Wonderland in Denver - ASHG 2024 Roundup

    Jason Fenwick on LinkedIn

  • Basepair Inc reposted this

    View profile for Simon Valentine, graphic

    CCO | Global Sales Leader | SaaS | Board Member | Genomics | Life Sciences | Commercial Strategy | Bioinformatics

    Wow, what an extremely insightful and busy time at #reInvent last week, packed with lots of exciting bioinformatics-related developments, meetings and of course the grand finale that is re:Play! Here are some key highlights: - End-to-end biological workflows: Basepair Inc was thrilled to be mentioned in the talk by Kevin Moore and Ariella Sasson from Amazon Web Services (AWS) on how AWS HealthOmics can be used to run groundbreaking end-to-end workflows using biological foundation models to accelerate the drug discovery process. - Scaling genomic operations: Natera presented their innovative use of AWS to scale clinical diagnostic operations, demonstrating how cloud computing is revolutionizing genomic analysis pipelines. - Biological foundation models: Merck shared insights on improving drug design using biological foundation models, emphasising they were partnering with AWS so they could focus on the science, not IT infrastructure - Generative AI in genomics: 2024 showcased real-world applications of GenAI in genomic data analysis and interpretation, promising faster insights from complex biological datasets. All these advancements demonstrate how AWS is empowering bioinformaticians and bench scientists alike to tackle complex biological problems with unprecedented speed and accuracy. At Basepair Inc we are excited to be a able to help democratize these approaches for the broader scientific community! #bioinformatics #ngs #genomics #sequencing

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
      +3

Similar pages

Browse jobs

Funding

Basepair Inc 7 total rounds

Last Round

Debt financing

US$ 1.1M

See more info on crunchbase